Boothbay Fund Management’s IO Biotech IOBT Stock Holding History

Boothbay Fund Management’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-451,852	Closed	-$26.5K	–	2428
2026 Q1	$26.5K	Hold	451,852	–	–	﹤0.01%	1952
2025 Q4	$275K	Sell	451,852 -139,328	-24%	-$104K	﹤0.01%	1485
2025 Q3	$215K	Buy	+591,180	New	+$1.02M	﹤0.01%	1620

Boothbay Fund Management's IOBT Position: Q2 2026 in Review

Boothbay Fund Management sold out of IO Biotech (IOBT) in Q2 2026, closing a stake of 451,852 shares — an estimated $26.5K sold.

Boothbay Fund Management first reported a position in IOBT in Q3 2025 and held it in 3 quarters. The position peaked at $275K in Q4 2025. 0 funds tracked by Wall St. Rank hold IOBT as of Q2 2026.

Boothbay Fund Management reported no remaining IO Biotech position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 451,852 IO Biotech shares in Q2 2026, an estimated $26.5K.
Boothbay Fund Management first reported a position in IO Biotech in Q3 2025 and held it in 3 quarters.
Boothbay Fund Management's IO Biotech position peaked at $275K in Q4 2025.
0 funds tracked by Wall St. Rank held IO Biotech as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.